Fate decision of mesenchymal stem cells: Adipocytes or osteoblasts?

Cell Death and Differentiation

Volumn 23, Issue 7, 2016, Pages 1128-1139

  Chen, Q ^a,b,d   Shou, P ^b   Zheng, C ^b   Jiang, M ^b   Cao, G ^b   Yang, Q ^b   Cao, J ^b   Xie, N ^b   Velletri, T ^b   Zhang, X ^b   Xu, C ^b   Zhang, L ^a,c   Yang, H ^a   Hou, J ^a   Wang, Y ^a,b   Shi, Y ^a,b,c  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

^c CHILD HEALTH INSTITUTE OF NEW JERSEY   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FIBROBLAST GROWTH FACTOR 2; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; DEXAMETHASONE; MICRORNA;

ADIPOCYTE; ADIPOGENESIS; CELL AGING; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL MATURATION; CELL SHAPE; HUMAN; IN VIVO STUDY; LIPID STORAGE; MESENCHYMAL STEM CELL; MITOCHONDRIAL RESPIRATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY; ANIMAL; CYTOLOGY; DRUG EFFECTS; MESENCHYMAL STROMA CELL; METABOLISM;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; DEXAMETHASONE; HUMANS; MESENCHYMAL STROMAL CELLS; MICRORNAS; OSTEOBLASTS; SIGNAL TRANSDUCTION;

EID: 84957921954     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2015.168     Document Type: Review

References (154)

1. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289: 1504-1508.
2. Caplan AI. Mesenchymal stem-cells. J Orthop Res 1991; 9: 641-650.
3. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7: 393-395.
4. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WWK, Gordon PL, Neel M et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309-313.
5. Pino AM, Rosen CJ, Rodriguez JP. In osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis. Biol Res 2012; 45: 279-287.
6. Kawai M, de Paula FJ, Rosen CJ. New insights into osteoporosis: the bone-fat connection. J Intern Med 2012; 272: 317-329.
7. Meunier P, Aaron J, Edouard C, Vignon G. Osteoporosis and replacement of cell populations of marrow by adipose tissue-a quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 1971; 80: 147-154.
8. Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M. Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2001; 2: 165-171.
9. Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma 2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 2004; 3: 379-389.
10. Bredella MA, Torriani M, Ghomi RH, Thomas BJ, Brick DJ, Gerweck AV et al. Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity 2011; 19: 49-53.
11. Misra M, Klibanski A. Anorexia nervosa, obesity and bone metabolism. Pediatr Endocrinol Rev 2013; 11: 21-33.
12. Cao JJ. Effects of obesity on bone metabolism. J Orthop Surg Res 2011; 6: 30.
13. Schwartz AV, Sigurdsson S, Hue TF, Lang TF, Harris TB, Rosen CJ et al. Vertebral bone marrow fat associated with lower trabecular BMD and prevalent vertebral fracture in older adults. J Clin Endocrinol Metab 2013; 98: 2294-2300.
14. Cohen A, Dempster DW, Stein EM, Nickolas TL, Zhou H, McMahon DJ et al. Increased marrow adiposity in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab 2012; 97: 2782-2791.
15. Dudley-Javoroski S, Shields RK. Dose estimation and surveillance of mechanical loading interventions for bone loss after spinal cord injury. Phys Ther 2008; 88: 387-396.
16. McGee-Lawrence ME, Carpio LR, Schulze RJ, Pierce JL, McNiven MA, Farr JN et al. Hdac3 deficiency increases marrow adiposity and induces lipid storage and glucocorticoid metabolism in osteochondroprogenitor cells. J Bone Miner Res 2016; 31: 116-128.
17. Motyl KJ, Raetz M, Tekalur SA, Schwartz RC, McCabe LR. CCAAT/enhancer binding protein beta-deficiency enhances type 1 diabetic bone phenotype by increasing marrow adiposity and bone resorption. Am J Physiol Regul Integr Comp Physiol 2011; 300: R1250-R1260.
18. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970; 3: 393-403.
19. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-4295.
20. Meirelles LDS, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204-2213.
21. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
22. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
23. Soleimani M, Nadri S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc 2009; 4: 102-106.
24. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997; 64: 278-294.
25. Ren GW, Zhang LY, Zhao X, Xu GW, Zhang YY, Roberts AI et al. Mesenchymal stem cellmediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008; 2: 141-150.
26. Lv FJ, Tuan RS, Cheung KM, Leung VY. Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells 2014; 32: 1408-1419.
27. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
28. Boxall SA, Jones E. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int 2012; 2012: 975871.
29. Jacobs SA, Roobrouck VD, Verfaillie CM, Van Gool SW. Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells. Immunol Cell Biol 2013; 91: 32-39.
30. Krampera M, Galipeau J, Shi Y, Tarte K, Sensebe L. Immunological characterization of multipotent mesenchymal stromal cells-The International Society for Cellular Therapy (ISCT) working proposal. Cytotherapy 2013; 15: 1054-1061.
31. Massague J. TGFbeta signalling in context. Nat Rev Mol Cell Biol 2012; 13: 616-630.
32. Chen G, Deng C, Li YP. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 2012; 8: 272-288.
33. zur Nieden NI, Kempka G, Rancourt DE, Ahr HJ. Induction of chondro-, osteo-and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: effect of cofactors on differentiating lineages. BMC Dev Biol 2005; 5: 1.
34. Kang Q, Song WX, Luo Q, Tang N, Luo J, Luo X et al. A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 2009; 18: 545-559.
35. Tang QQ, Otto TC, Lane MD. Commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci USA 2004; 101: 9607-9611.
36. Sottile V, Seuwen K. Bone morphogenetic protein-2 stimulates adipogenic differentiation of mesenchymal precursor cells in synergy with BRL 49653 (rosiglitazone). FEBS Lett 2000; 475: 201-204.
37. Deng ZL, Sharff KA, Tang N, Song WX, Luo J, Luo X et al. Regulation of osteogenic differentiation during skeletal development. Front Biosci 2008; 13: 2001-2021.
38. Clevers H, Loh KM, Nusse R. Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science 2014; 346: 1248012.
39. Sherwood V. WNT signaling: an emerging mediator of cancer cell metabolism? Mol Cell Biol 2015; 35: 2-10.
40. Holland JD, Klaus A, Garratt AN, Birchmeier W. Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol 2013; 25: 254-264.
41. Muruganandan S, Roman AA, Sinal CJ. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci 2009; 66: 236-253.
42. Bennett CN, Ross SE, Longo KA, Bajnok L, Hemati N, Johnson KW et al. Regulation of Wnt signaling during adipogenesis. J Biol Chem 2002; 277: 30998-31004.
43. Yuan Z, Li Q, Luo S, Liu Z, Luo D, Zhang B et al. PPARgamma and Wnt signaling in adipogenic and osteogenic differentiation of mesenchymal stem cells. Curr Stem Cell Res Ther 2015; 10: 1-10.
44. Park HW, Kim YC, Yu B, Moroishi T, Mo JS, Plouffe SW et al. Alternative Wnt signaling activates YAP/TAZ. Cell 2015; 162: 780-794.
45. Byun MR, Hwang JH, Kim AR, Kim KM, Hwang ES, Yaffe MB et al. Canonical Wnt signalling activates TAZ through PP1A during osteogenic differentiation. Cell Death Differ 2014; 21: 854-863.
46. Bennett CN, Ouyang H, Ma YL, Zeng Q, Gerin I, Sousa KM et al. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J Bone Miner Res 2007; 22: 1924-1932.
47. Stevens JR, Miranda-Carboni GA, Singer MA, Brugger SM, Lyons KM, Lane TF. Wnt10b deficiency results in age-dependent loss of bone mass and progressive reduction of mesenchymal progenitor cells. J Bone Miner Res 2010; 25: 2138-2147.
48. Arango NA, Szotek PP, Manganaro TF, Oliva E, Donahoe PK, Teixeira J. Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev Biol 2005; 288: 276-283.
49. Lin GL, Hankenson KD. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem 2011; 112: 3491-3501.
50. Ross DA, Rao PK, Kadesch T. Dual roles for the Notch target gene Hes-1 in the differentiation of 3T3-L1 preadipocytes. Mol Cell Biol 2004; 24: 3505-3513.
51. Song BQ, Chi Y, Li X, Du WJ, Han ZB, Tian JJ et al. Inhibition of Notch signaling promotes the adipogenic differentiation of mesenchymal stem cells through autophagy activation and PTEN-PI3K/AKT/mTOR pathway. Cell Physiol Biochem 2015; 36: 1991-2002.
52. Shimizu T, Tanaka T, Iso T, Matsui H, Ooyama Y, Kawai-Kowase K et al. Notch signaling pathway enhances bone morphogenetic protein 2 (BMP2) responsiveness of Msx2 gene to induce osteogenic differentiation and mineralization of vascular smooth muscle cells. J Biol Chem 2011; 286: 19138-19148.
53. Fontaine C, Cousin W, Plaisant M, Dani C, Peraldi P. Hedgehog signaling alters adipocyte maturation of human mesenchymal stem cells. Stem Cells 2008; 26: 1037-1046.
54. Kim WK, Meliton V, Bourquard N, Hahn TJ, Parhami F. Hedgehog signaling and osteogenic differentiation in multipotent bone marrow stromal cells are inhibited by oxidative stress. J Cell Biochem 2010; 111: 1199-1209.
55. James AW, Pang S, Askarinam A, Corselli M, Zara JN, Goyal R et al. Additive effects of sonic hedgehog and Nell-1 signaling in osteogenic versus adipogenic differentiation of human adipose-derived stromal cells. Stem Cells Dev 2012; 21: 2170-2178.
56. Li L, Dong Q, Wang Y, Feng Q, Zhou P, Ou X et al. Hedgehog signaling is involved in the BMP9-induced osteogenic differentiation of mesenchymal stem cells. Int J Mol Med 2015; 35: 1641-1650.
57. Spinella-Jaegle S, Rawadi G, Kawai S, Gallea S, Faucheu C, Mollat P et al. Sonic hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage and abolishes adipocytic differentiation. J Cell Sci 2001; 114: 2085-2094.
58. Krampera M, Pasini A, Rigo A, Scupoli MT, Tecchio C, Malpeli G et al. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood 2005; 106: 59-66.
59. Gruber R, Karreth F, Kandler B, Fuerst G, Rot A, Fischer MB et al. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets 2004; 15: 29-35.
60. Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M, Mann M. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 2005; 308: 1472-1477.
61. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 2005; 16: 139-149.
62. Jackson RA, Nurcombe V, Cool SM. Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene 2006; 379: 79-91.
63. Woei NgK, Speicher T, Dombrowski C, Helledie T, Haupt LM, Nurcombe V et al. Osteogenic differentiation of murine embryonic stem cells is mediated by fibroblast growth factor receptors. Stem Cells Dev 2007; 16: 305-318.
64. Ling L, Murali S, Dombrowski C, Haupt LM, Stein GS, van Wijnen AJ et al. Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells. J Cell Physiol 2006; 209: 811-825.
65. Neubauer M, Fischbach C, Bauer-Kreisel P, Lieb E, Hacker M, Tessmar J et al. Basic fibroblast growth factor enhances PPARgamma ligand-induced adipogenesis of mesenchymal stem cells. FEBS Lett 2004; 577: 277-283.
66. Neubauer M, Hacker M, Bauer-Kreisel P, Weiser B, Fischbach C, Schulz MB et al. Adipose tissue engineering based on mesenchymal stem cells and basic fibroblast growth factor in vitro. Tissue Eng 2005; 11: 1840-1851.
67. Sakaue H, Konishi M, Ogawa W, Asaki T, Mori T, Yamasaki M et al. Requirement of fibroblast growth factor 10 in development of white adipose tissue. Genes Dev 2002; 16: 908-912.
68. Augello A, De Bari C. The regulation of differentiation in mesenchymal stem cells. Hum Gene Ther 2010; 21: 1226-1238.
69. Jeong BC, Kang IH, Hwang YC, Kim SH, Koh JT. MicroRNA-194 reciprocally stimulates osteogenesis and inhibits adipogenesis via regulating COUP-TFII expression. Cell Death Dis 2014; 5: e1532.
70. Tome M, Lopez-Romero P, Albo C, Sepulveda JC, Fernandez-Gutierrez B, Dopazo et al. miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ 2011; 18: 985-995.
71. Wang J, Guan X, Guo F, Zhou J, Chang A, Sun B et al. miR-30e reciprocally regulates the differentiation of adipocytes and osteoblasts by directly targeting low-density lipoprotein receptor-related protein 6. Cell Death Dis 2013; 4: e845.
72. Huang J, Zhao L, Xing L, Chen D. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 2010; 28: 357-364.
73. Zhang JF, Fu WM, He ML,Wang H,Wang WM, Yu SC et al. MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol Biol Cell 2011; 22: 3955-3961.
74. Karbiener M, Fischer C, Nowitsch S, Opriessnig P, Papak C, Ailhaud G et al. microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochem Biophys Res Commun 2009; 390: 247-251.
75. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF. Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci USA 1997; 94: 10669-10674.
76. Kim YJ, Hwang SJ, Bae YC, Jung JS. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 2009; 27: 3093-3102.
77. Yang Z, Bian CJ, Zhou H, Huang S, Wang SH, Liao LM et al. MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1. Stem Cells Dev 2011; 20: 259-267.
78. Eskildsen T, Taipaleenmaki H, Stenvang J, Abdallah BM, Ditzel N, Nossent AY et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA 2011; 108: 6139-6144.
79. Lian JB, Stein GS, van Wijnen AJ, Stein JL, Hassan MQ, Gaur T et al. MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol 2012; 8: 212-227.
80. Fang S, Deng Y, Gu P, Fan X. MicroRNAs regulate bone development and regeneration. Int J Mol Sci 2015; 16: 8227-8253.
81. Hamam D, Ali D, Kassem M, Aldahmash A, Alajez NM. microRNAs as regulators of adipogenic differentiation of mesenchymal stem cells. Stem Cells Dev 2015; 24: 417-425.
82. Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho et al. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 2008; 22: 2941-2952.
83. Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991; 5: 1538-1552.
84. Kushwaha P, Khedgikar V, Gautam J, Dixit P, Chillara R, Verma et al. A novel therapeutic approach with Caviunin-based isoflavonoid that en routes bone marrow cells to bone formation via BMP2/Wnt-beta-catenin signaling. Cell Death Differ 2014; 5: e1422.
85. Kim J, Ko J. A novel PPARgamma2 modulator sLZIP controls the balance between adipogenesis and osteogenesis during mesenchymal stem cell differentiation. Cell Death Differ 2014; 21: 1642-1655.
86. Tang QQ, Lane MD. Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem 2012; 81: 715-736.
87. Lin FT, Lane MD. CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc Natl Acad Sci USA 1994; 91: 8757-8761.
88. Komori T. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 2006; 99: 1233-1239.
89. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108: 17-29.
90. Komori T. Regulation of osteoblast differentiation by Runx2. Adv Exp Med Biol 2010; 658: 43-49.
91. Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res 2010; 339: 189-195.
92. Wei J, Shimazu J, Makinistoglu MP, Maurizi A, Kajimura D, Zong H et al. Glucose uptake and Runx2 synergize to orchestrate osteoblast differentiation and bone formation. Cell 2015; 161: 1576-1591.
93. Maruyama Z, Yoshida CA, Furuichi T, Amizuka N, Ito M, Fukuyama R et al. Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev Dyn 2007; 236: 1876-1890.
94. Brindle PK, Montminy MR. The CREB family of transcription activators. Curr Opin Genet Dev 1992; 2: 199-204.
95. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA. Peroxisome proliferatoractivated receptors alpha and gamma are activated by indomethacin and other nonsteroidal anti-inflammatory drugs. J Biol Chem 1997; 272: 3406-3410.
96. Coelho MJ, Fernandes MH. Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, beta-glycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials 2000; 21: 1095-1102.
97. Franceschi RT, Iyer BS, Cui Y. Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res 1994; 9: 843-854.
98. Xiao Y, Peperzak V, van Rijn L, Borst J, de Bruijn JD. Dexamethasone treatment during the expansion phase maintains stemness of bone marrow mesenchymal stem cells. J Tissue Eng Regen Med 2010; 4: 374-386.
99. Kim CH, Cheng SL, Kim GS. Effects of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells: possible mechanisms of glucocorticoid-induced bone loss. J Endocrinol 1999; 162: 371-379.
100. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 2006; 126: 677-689.
101. Marie PJ, Hay E, Saidak Z. Integrin and cadherin signaling in bone: role and potential therapeutic targets. Trends Endocrinol Metab 2014; 25: 567-575.
102. Ge C, Yang Q, Zhao G, Yu H, Kirkwood KL, Franceschi RT. Interactions between extracellular signal-regulated kinase 1/2 and p38 MAP kinase pathways in the control of RUNX2 phosphorylation and transcriptional activity. J Bone Miner Res 2012; 27: 538-551.
103. Moon YS, Smas CM, Lee K, Villena JA, Kim KH, Yun EJ et al. Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity. Mol Cell Biol 2002; 22: 5585-5592.
104. Sul HS. Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate. Mol Endocrinol 2009; 23: 1717-1725.
105. Wang Y, Zhao L, Smas C, Sul HS. Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Mol Cell Biol 2010; 30: 3480-3492.
106. Taleb S, Cancello R, Clement K, Lacasa D. Cathepsin S promotes human preadipocyte differentiation: possible involvement of fibronectin degradation. Endocrinology 2006; 147: 4950-4959.
107. Muller P, Langenbach A, Kaminski A, Rychly J. Modulating the actin cytoskeleton affects mechanically induced signal transduction and differentiation in mesenchymal stem cells. PLoS One 2013; 8: e71283.
108. Li R, Liang L, Dou Y, Huang Z, Mo H, Wang Y et al. Mechanical strain regulates osteogenic and adipogenic differentiation of bone marrow mesenchymal stem cells. Biomed Res Int 2015; 2015: 873251.
109. Thompson WR, Guilluy C, Xie Z, Sen B, Brobst KE, Yen SS et al. Mechanically activated Fyn utilizes mTORC2 to regulate RhoA and adipogenesis in mesenchymal stem cells. Stem Cells 2013; 31: 2528-2537.
110. Sen B, Xie Z, Case N, Thompson WR, Uzer G, Styner M et al. mTORC2 regulates mechanically induced cytoskeletal reorganization and lineage selection in marrow-derived mesenchymal stem cells. J Bone Miner Res 2014; 29: 78-89.
111. Chen Q, Shou P, Zhang L, Xu C, Zheng C, Han Y et al. An osteopontin-integrin interaction plays a critical role in directing adipogenesis and osteogenesis by mesenchymal stem cells. Stem Cells 2014; 32: 327-337.
112. Dalby MJ, Gadegaard N, Tare R, Andar A, Riehle MO, Herzyk P et al. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nat Mater 2007; 6: 997-1003.
113. Kilian KA, Bugarija B, Lahn BT, Mrksich M. Geometric cues for directing the differentiation of mesenchymal stem cells. Proc Natl Acad Sci USA 2010; 107: 4872-4877.
114. D'Arcangelo E, McGuigan AP. Micropatterning strategies to engineer controlled cell and tissue architecture in vitro. Biotechniques 2015; 58: 13-23.
115. Chen CS, Mrksich M, Huang S, Whitesides GM, Ingber DE. Geometric control of cell life and death. Science 1997; 276: 1425-1428.
116. McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 2004; 6: 483-495.
117. Pampaloni F, Reynaud EG, Stelzer EH. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 2007; 8: 839-845.
118. Kloxin AM, Kasko AM, Salinas CN, Anseth KS. Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science 2009; 324: 59-63.
119. Sundelacruz S, Levin M, Kaplan DL. Membrane potential controls adipogenic and osteogenic differentiation of mesenchymal stem cells. PLoS One 2008; 3: e3737.
120. Shi Y, Fu Y, Tong W, Geng Y, Lui PP, Tang T et al. Uniaxial mechanical tension promoted osteogenic differentiation of rat tendon-derived stem cells (rTDSCs) via the Wnt5a-RhoA pathway. J Cell Biochem 2012; 113: 3133-3142.
121. Yourek G, McCormick SM, Mao JJ, Reilly GC. Shear stress induces osteogenic differentiation of human mesenchymal stem cells. Regen Med 2010; 5: 713-724.
122. Sun HJ, Bahk YY, Choi YR, Shim JH, Han SH, Lee JW. A proteomic analysis during serial subculture and osteogenic differentiation of human mesenchymal stem cell. J Orthop Res 2006; 24: 2059-2071.
123. Almeida M, Ambrogini E, Han L, Manolagas SC, Jilka RL. Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. J Biol Chem 2009; 284: 27438-27448.
124. Kousteni S. FoxO1, the transcriptional chief of staff of energy metabolism. Bone 2012; 50: 437-443.
125. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrowderived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 2008; 129: 163-173.
126. Bruedigam C, Eijken M, Koedam M, van de Peppel J, Drabek K, Chiba H et al. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone. Stem Cells 2010; 28: 916-927.
127. Zhang Y, Marsboom G, Toth PT, Rehman J. Mitochondrial respiration regulates adipogenic differentiation of human mesenchymal stem cells. PLoS One 2013; 8: e77077.
128. Atashi F, Modarressi A, Pepper MS. The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: a review. Stem Cells Dev 2015; 24: 1150-1163.
129. Wilson-Fritch L, Burkart A, Bell G, Mendelson K, Leszyk J, Nicoloro S et al. Mitochondrial biogenesis and remodeling during adipogenesis and in response to the insulin sensitizer rosiglitazone. Mol Cell Biol 2003; 23: 1085-1094.
130. Tormos KV, Anso E, Hamanaka RB, Eisenbart J, Joseph J, Kalyanaraman B et al. Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab 2011; 14: 537-544.
131. Xu N, Liu H, Qu F, Fan J, Mao K, Yin Y et al. Hypoxia inhibits the differentiation of mesenchymal stem cells into osteoblasts by activation of Notch signaling. Exp Mol Pathol 2013; 94: 33-39.
132. Yang DC, Yang MH, Tsai CC, Huang TF, Chen YH, Hung SC. Hypoxia inhibits osteogenesis in human mesenchymal stem cells through direct regulation of RUNX2 by TWIST. PLoS One 2011; 6: e23965.
133. Hsu SH, Chen CT, Wei YH. Inhibitory effects of hypoxia on metabolic switch and osteogenic differentiation of human mesenchymal stem cells. Stem Cells 2013; 31: 2779-2788.
134. Beegle J, Lakatos K, Kalomoiris S, Stewart H, Isseroff RR, Nolta JA et al. Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo. Stem Cells 2015; 33: 1818-1828.
135. Valorani MG, Montelatici E, Germani A, Biddle A, D'Alessandro D, Strollo R et al. Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potentials. Cell Prolif 2012; 45: 225-238.
136. Dos Santos F, Andrade PZ, Boura JS, Abecasis MM, da Silva CL, Cabral JM. Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia. J Cell Physiol 2010; 223: 27-35.
137. Buravkova LB, Andreeva ER, Gogvadze V, Zhivotovsky B. Mesenchymal stem cells and hypoxia: where are we? Mitochondrion 2014 (19 Pt A): 105-112.
138. Peng XD, Xie H, Zhao Q, Wu XP, Sun ZQ, Liao EY. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 2008; 387: 31-35.
139. Gomez-Ambrosi J, Rodriguez A, Catalan V, Fruhbeck G. The bone-adipose axis in obesity and weight loss. Obes Surg 2008; 18: 1134-1143.
140. Yang DC, Tsay HJ, Lin SY, Chiou SH, Li MJ, Chang TJ et al. cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. PLoS One 2008; 3: e1540.
141. Han GS, Jing YY, Zhang YH, Yue ZJ, Hu XW, Wang LX et al. Osteogenic differentiation of bone marrow mesenchymal stem cells by adenovirus-mediated expression of leptin. Regul Pept 2010; 163: 107-112.
142. Zhou J, Guo F, Wang G, Wang J, Zheng F, Guan X et al. miR-20a regulates adipocyte differentiation by targeting lysine-specific demethylase 6b and transforming growth factorbeta signaling. Int J Obes (Lond) 2015; 39: 1282-1291.
143. Su X, Liao L, Shuai Y, Jing H, Liu S, Zhou H et al. MiR-26a functions oppositely in osteogenic differentiation of BMSCs and ADSCs depending on distinct activation and roles of Wnt and BMP signaling pathway. Cell Death Dis 2015; 6: e1851.
144. Li Y, Fan L, Hu J, Zhang L, Liao L, Liu S et al. MiR-26a rescues bone regeneration deficiency of mesenchymal stem cells derived from osteoporotic mice. Mol Ther 2015; 23: 1349-1357.
145. Ding W, Li J, Singh J, Alif R, Vazquez-Padron RI, Gomes SA et al. miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/-mice. Cardiovasc Res 2015; 106: 131-142.
146. Gernapudi R, Wolfson B, Zhang Y, Yao Y, Yang P, Asahara H et al. miR-140 promotes expression of long non-coding RNA NEAT1 in adipogenesis. Mol Cell Biol 2015: MCB.00702-00715.
147. Cao Y, Lv Q, Lv C. MicroRNA-153 suppresses the osteogenic differentiation of human mesenchymal stem cells by targeting bone morphogenetic protein receptor type II. Int J Mol Med 2015; 36: 760-766.
148. Li CJ, Cheng P, Liang MK, Chen YS, Lu Q, Wang JY et al. MicroRNA-188 regulates agerelated switch between osteoblast and adipocyte differentiation. J Clin Invest 2015; 125: 1509-1522.
149. Chen X, Gu S, Chen BF, Shen WL, Yin Z, Xu GW et al. Nanoparticle delivery of stable miR-199a-5p agomir improves the osteogenesis of human mesenchymal stem cells via the HIF1a pathway. Biomaterials 2015; 53: 239-250.
150. Li H, Li T, Fan J, Li T, Fan L, Wang S et al. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway. Cell Death Differ 2015; 22: 1935-1945.
151. Guan X, Gao Y, Zhou J, Wang J, Zheng F, Guo F et al. miR-223 regulates adipogenic and osteogenic differentiation of mesenchymal stem cells through a C/EBPs/miR-223/FGFR2 regulatory feedback loop. Stem Cells 2015; 33: 1589-1600.
152. Hamam D, Ali D, Vishnubalaji R, Hamam R, Al-Nbaheen M, Chen L et al. microRNA-320/RUNX2 axis regulates adipocytic differentiation of human mesenchymal (skeletal) stem cells. Cell Death Dis 2014; 5: e1499.
153. Kraus M, Greither T, Wenzel C, Brauer-Hartmann D, Wabitsch M, Behre HM. Inhibition of adipogenic differentiation of human SGBS preadipocytes by androgen-regulated microRNA miR-375. Mol Cell Endocrinol 2015; 414: 177-185.
154. Zhang Z, Hou C, Meng F, Zhao X, Zhang Z, Huang G et al. MiR-455-3p regulates early chondrogenic differentiation via inhibiting Runx2. FEBS Lett 2015; 589: 3671-3678.